Table 5. Estimation of potentially nephrotoxic drugs given to renally compromised hospitalized stroke patients.
| Different drugs administered to hospitalized stroke patients | Estimation and frequency of Renally compromised hospitalized stroke patients (n) | p-value | |
|---|---|---|---|
| Yes | No | ||
| Piperacillin-Tazobactum | 50 | 80 | 0.047 |
| Ceftriaxone | 71 | 126 | 0.035 |
| Vancomycin | 39 | 58 | 0.047 |
| Meropenem | 43 | 63 | 0.025 |
| Amikacin | 10 | 21 | 0.945 |
| Ciprofloxcin | 12 | 14 | 0.125 |
| Levofloxacin | 10 | 16 | 0.516 |
| Cefixime | 37 | 82 | 0.584 |
| Azithromycin | 13 | 38 | 0.128 |
| Cefoperazone-Sulbactum | 01 | 00 | 0.183 |
| Co-amoxiclav | 04 | 04 | 0.403 |
| Moxifloxacin | 17 | 17 | 0.057 |
| Gentamicin | 10 | 16 | 0.516 |
| Omeprazole | 73 | 141 | 0.281 |
| Levetiracetum | 38 | 59 | 0.087 |
| Acyclovir | 11 | 27 | 0.583 |
| Dexamethasone | 27 | 41 | 0.155 |
| Diclofenac sodium | 10 | 35 | 0.095 |
| Paracetamol | 64 | 103 | 0.008 |
| Ibuprofen | 16 | 39 | 0.507 |